Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results